
Byrnihat, Delhi top two most polluted cities in India till June-end, says new analysis
Byrnihat's average particulate matter 2.5 (PM 2.5) concentration was 133 micrograms/cubic metre (ug/m3) while Delhi's PM 2.5 average stood at 87 ug/m3. PM 2.5 pollutants are very fine and easily inhalable, and can enter the bloodstream through the lungs.
As per the national ambient air quality standards (NAAQS), 40 ug/m3 is the prescribed limit for PM 2.5 levels.
Most days in Delhi (63) were in the moderate category, which reflects air quality concentration in the 61-90 ug/m3 range. For 29 days, the city's air quality was in the very poor quality category.
Sasaram, Patna, and Rajgir in Bihar, and Talcher and Rourkela in Odisha were the other cities in the top 10 most polluted cities till June. In the January to June corresponding period for 2024, these same 10 cities were the most polluted in the country, with Byrnihat and Delhi occupying the same spots.
The analysis was based on air quality data drawn from the government's continuous ambient air quality monitoring stations (CAAQMS) in 293 cities.
'Among these, 122 cities exceeded India's annual National Ambient Air Quality Standards of 40 micrograms/metre cube, while 117 cities remained below this threshold,' the analysis stated.
Meanwhile, Mizoram's capital Aizawl was the cleanest city in the country. Its average PM 2.5 concentration was 8 ug/m3, which was still higher than the World Health Organization's (WHO) prescribed 5 ug/m3 level.
Tirupur and Tirunelveli in Tamil Nadu, Bareilly and Vrindavan in Uttar Pradesh, Maihar in Madhya Pradesh, Imphal in Manipur, and Chamrajanagar and Chikkamagaluru in Karnataka were the other cities among the top 10 cleanest cities.
Among the 131 cities covered under the National Clean Air Programme (NCAP), 98 have CAAMS installed. Of these, 55 cities exceeded the national standards. Among the 141 cities not covered under NCAP, 67 cities exceeded the national standards.
To underline the depth of non-compliance, the analysis pointed out that till now, 259 of the 293 cities with CAAMS had already overshot their annual particulate matter 2.5 standards. Overshoot days signify that cities have already crossed the threshold of their annual standards. Thus, even if the air quality improved, it would not meet its annual standards.
An award-winning journalist with 14 years of experience, Nikhil Ghanekar is an Assistant Editor with the National Bureau [Government] of The Indian Express in New Delhi. He primarily covers environmental policy matters which involve tracking key decisions and inner workings of the Ministry of Environment, Forest and Climate Change. He also covers the functioning of the National Green Tribunal and writes on the impact of environmental policies on wildlife conservation, forestry issues and climate change.
Nikhil joined The Indian Express in 2024. Originally from Mumbai, he has worked in publications such as Tehelka, Hindustan Times, DNA Newspaper, News18 and Indiaspend. In the past 14 years, he has written on a range of subjects such as sports, current affairs, civic issues, city centric environment news, central government policies and politics. ... Read More
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hindu
8 hours ago
- The Hindu
All you need to know about: rabies
The Supreme Court's recent ruling directing the Delhi government and local bodies to immediately capture stray dogs, detain them in pounds created across the national capital territory and never let them loose back into public spaces, has ignited a controversy. One of the points the court made was about children lost to rabies due to stray dog bites. What is rabies and what is the extent of the public health burden caused by it? Here is all you need to know about rabies. What is rabies? Rabies is a deadly, fatal, zoonotic viral disease. The rabies virus (RABV) is generally transmitted through the bite or scratch of an infected animal. Rabies infects mammals, including dogs, cats, livestock and wildlife. Other animals that carry rabies include: bats, raccoons, skunks and foxes. According to the World Health Organization (WHO) however, dog bites and scratches cause 99% of the human rabies cases. In rare cases, rabies is transmitted through the infected saliva of an animal coming into contact with an open wound or mucous membranes such as in the eyes or mouth. What makes this virus dangerous is that once clinical symptoms begin, there is no cure: it is fatal. However, rabies can be prevented through prompt vaccination after exposure. The WHO classifies rabies as a neglected tropical disease (NTD) and states that children between the ages of 5 and 14 are frequent victims. What are the signs and symptoms of rabies? The rabies virus has an incubation period. This means it can spend several days or weeks (up to two or three months) in the body before symptoms appear. The incubation can period can vary based on factors such as the location of the wound. It is during the next phase, when the virus travels to the central nervous system, known as the prodromal phase that symptoms appear. Initial symptoms may be similar to those of the flu and may include: fever, headaches, discomfort, vomiting, weakness and prickling or tingling at the site of the bite. The disease then progresses into a severe form, usually about two weeks after the first symptoms. At this stage, the acute neurologic phase, the rabies virus begins damaging the brain and spinal cord. In a majority of people symptoms of 'furious rabies' appear, and these include aggressive behaviour, hallucinations, hyperactivity, fear of water (hydrophobia), excessive salivation, fear of air or drafts and delirium. A smaller number of patients have symptoms of 'paralytic rabies' which involves paralysis of the muscles and weakness, starting from the site of the bite and progressing to the rest of the body, eventually leading to a coma. Furious rabies usually lasts a few days while paralytic rabies can last longer. The WHO states that the paralytic form of rabies is often misdiagnosed, contributing to the under-reporting of the disease. What is the vaccination available? There are currently no WHO-approved tools to diagnose rabies prior to the onset of clinical symptoms, making it crucial to see a healthcare provider immediately after a bite, scratch or contact with a wild animal, or a potentially infected pet animal. Healthcare providers must make an accurate risk assessment to decide on vaccination. The wound must be cleaned gently and thoroughly as well. Vaccines for rabies are: pre-exposure prophylaxis (PrEP) which is recommended for people in high-risk professions where they may come into contact with infected animals or those travelling to such areas and post-exposure prophylaxis (PEP), which is given after exposure, and which prevents the virus from entering the central nervous system. It is important to note that taking the PrEP does not mean that PEP is not needed: even those who have taken the PrEP must seek care after exposure. As listed under the WHO - Prequalification of Medical Products, as of 2024, there are only three WHO pre-qualified human rabies vaccines available globally: RABIVAX-S by Serum Institute of India Pvt. Ltd., VaxiRab N by Zydus Lifesciences Limited, and VERORAB by Sanofi Pasteur. What do you do if bitten or scratched by an animal? If you've been bitten by animal that may have rabies, or even scratched or licked it is important to seek medical attention. Wash the wound thoroughly with soap and water and then go to your healthcare provider, giving as much detail as possible about the animal and the kind of contact. The post exposure prophylaxis (PEP) rabies vaccine usually consists of four shots over 14 days. Your doctor may also give you shots of human rabies immunoglobulin, given into or around the wound in order to give the body antibodies to destroy the virus around the wound. (This is not taken if a vaccination has already been taken prior to exposure). If treatment is availed of promptly after exposure, it is usually effective at preventing rabies. What is the situation in India? In India, there were more than 37 lakh cases of dog bites and 54 suspected human rabies deaths reported during 2024, according to a written reply given by S.P. Singh Baghel, Minister of State for Fisheries, Animal Husbandry and Dairying to the Lok Sabha. A January 2025 research paper, 'Estimates of the burden of human rabies deaths and animal bites in India, 2022–23: a community-based cross-sectional survey and probability decision-tree modelling study' however found that the estimated human rabies death occurring annually in India was 5,726. It also found gaps in vaccine access and completion of vaccine courses. The WHO notes that India is endemic for rabies, and accounts for 36% of the world's rabies deaths.


Time of India
9 hours ago
- Time of India
Covid variant XFG surges 14% in US as WHO tracks spread to 38 nations, India confirms 163 cases; here's what we know so far
The United States is reporting a steady increase in Covid-19 cases linked to the XFG variant, now the country's third-most common strain this summer. Also known as 'Stratus,' XFG is a recombinant of two earlier Omicron subvariants—LF.7 and LP.8.1.2—first identified in Southeast Asia in January 2025. The World Health Organization (WHO) has placed XFG under its 'variant under monitoring' category. This means that while it is not considered a major health threat at present, its spread is being closely tracked. Global and national spread Data from the US Centers for Disease Control and Prevention (CDC) shows that XFG represented 0 per cent of US cases in March, rising to 2 per cent in April, 6 per cent in May, and 14 per cent by late June. This puts it behind only two other variants in prevalence. The variant has also been reported in several European nations. WHO figures indicate its global share rose from about 7 per cent in early May to 22.7 per cent by late June, spanning at least 38 countries. ⚠️ BREAKING: COVID-19 Cases Rising in 25 US States, Including California, Florida, and Texas, Signaling Onset of 'Summer Wave' In India, the Indian SARS-CoV-2 Genomics Consortium (Insacog) recorded 163 confirmed cases of XFG by the end of June. Symptoms and health impact So far, XFG does not appear to cause symptoms different from or more severe than those seen with other Omicron strains. Variants like XFG can develop when a person is infected with two versions of the virus simultaneously, allowing genetic material to mix. Reported symptoms include: Fever or chills Cough Shortness of breath or breathing difficulty Sore throat Nasal congestion or runny nose New loss of taste or smell Fatigue Muscle or body aches Headache Nausea or vomiting The CDC advises immediate medical help for chest pain, confusion, difficulty staying awake, or pale/blue lips, skin, or nail beds. Expert assessment and vaccination guidance WHO and expert evaluations confirm that: Public health risk remains low No evidence of increased severity Current vaccines continue to protect against symptomatic and severe illness Precautionary measures Health authorities recommend the following steps: Get tested if symptoms appear Stay home if unwell Maintain good hygiene practices Keep vaccinations and boosters up to date While XFG is spreading quickly, current evidence suggests that with routine precautions and existing vaccination coverage, the impact can be managed effectively. To stay updated on the stories that are going viral follow Indiatimes Trending.
&w=3840&q=100)

Business Standard
a day ago
- Business Standard
New Covid variant on the rise in US: What you need to know about XFG
The United States is witnessing a sharp rise in Covid-19 cases driven by the XFG variant, now its third-most common summer strain. Also known as 'Stratus', XFG is a genetic blend of two earlier Omicron variants—LF.7 and LP.8.1.2. It was first detected in Southeast Asia in January 2025 and belongs to the Omicron group of variants. The World Health Organization (WHO) lists XFG as a variant under monitoring (VUM), meaning it is not currently considered a major public health threat but is being closely tracked due to its rapid spread. How widespread is XFG? According to the US Centers for Disease Control and Prevention (CDC), XFG accounted for 0 per cent of cases in March, rising to 2 per cent in April, 6 per cent in May, and 14 per cent by late June - making it the third-most common variant in the country. It has also spread across multiple European nations. Globally, WHO data shows XFG's share climbed from around 7 per cent in early May to 22.7 per cent by the end of June, across at least 38 countries. In India, the Indian SARS-CoV-2 Genomics Consortium (Insacog) has reported 163 cases of XFG till June. What are the symptoms? Like other Omicron variants, XFG appears to cause no different or more severe symptoms. Variants such as XFG can emerge when a person is infected with two versions of the virus at once, enabling them to swap genetic material. Common symptoms include: Fever or chills Cough Shortness of breath or difficulty breathing Sore throat Congestion or runny nose New loss of taste or smell Fatigue Muscle or body aches Headache Nausea or vomiting The CDC advises urgent medical attention for chest pain, confusion, difficulty staying awake, or pale/blue lips, skin, or nail beds. Is XFG more severe or resistant? Dr Subhash Verma, professor of microbiology and immunology at the University of Nevada, Reno, told USA Today: 'There is currently no clear evidence that XFG causes more severe disease or significantly different symptoms than earlier Omicron variants. Importantly, there are no immediate public health concerns associated with this variant.' Current WHO and expert assessments indicate: Public health risk remains low No evidence of increased severity Current vaccines continue to protect against symptomatic and severe illness What precautions people can take Test if symptoms appear Stay home when unwell Maintain good hygiene Keep vaccinations and boosters up to date Also Read: